A multiple sclerosis suited toxic rat model, cuprizone (compared with standard, a several times higher regimen, 2.5% of diet regimen + 1 g/kg intragastrically/day) was combined with BPC 157 (in drinking water 0.16 g or 0.16 ng/ml/12 ml/day/rat + 10 g or 10 ng/kg intragastrically/day) till the sacrifice at day 4
Oral administration is supported by research showing BPC-157's gastric stability and absorption, making it viable for gastrointestinal conditions or patients uncomfortable with injections
Fibroblasts are specialized cells deemed essential in producing new collagen fibers, vital components for structural support in various tissues
Additional quality assessments evaluate physicochemical characteristics relevant to laboratory use, including solubility, molecular integrity, and stability under recommended storage conditions
Currently, there is not enough high-quality clinical evidence to support the use of BPC-157 for weight management or fat loss in humans